|
XLO Xilio Therapeutics Inc 1840233 |
| Balance Sheet |
|
Current Assets
|
$145,468,000.00 |
|
Assets
|
$154,254,000.00 |
|
Current Liabilities
|
$34,198,000.00 |
|
Liabilities
|
$81,990,000.00 |
|
Equity
|
$72,264,000.00 |
|
Shares Out
|
6580149.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-41,105,000.00 |
|
Investing Cash Flow
|
$-575,000.00 |
| Market Analysis |
Market Cap
|
$49,351,117.50 |
|
Price
|
$7.99 |
|
BVPS
|
10.98 |
|
PB
|
0.68 |
|
EPS
|
-0.33 |
|
PS
|
0.81 |
|
FCF
|
$-41,680,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-10-01 09:31:44 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-10-26 10:00:32 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view XLO documents filed with the SEC.
XLO Filings
Clear
